For this case, plaintiffs attorneys will like present scientific research exploring the possible association between Mounjaro and other GLP-1 drugs and vision loss related to NAION
Thats why we carefully consider the use of GLP-1 medications as part of an individualized treatment plan, alongside physical therapy, nutritional counseling, and other medical interventions
DOI: 10.1136/bmjmed-2025-002150,
Retatrutide is not yet FDA approved
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised semaglutide tablets for use in adults with obesity, or those who are overweight with at least one weight-related comorbidity, alongside a reduced-calorie diet and increased physical activity
Want predictable transitions rather than sudden changes